ProPhase Labs Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
September 30 2020 - 8:30AM
ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science
and technology company, has engaged international investor
relations specialists MZ Group (MZ) to lead a comprehensive
strategic investor relations and financial communications program
across all key markets.
MZ Group will work closely with ProPhase
management to develop and implement a comprehensive capital markets
strategy designed to increase the Company’s visibility throughout
the investment community. The campaign will highlight how ProPhase,
a company with deep experience with Over-The-Counter (OTC) consumer
healthcare products, develops, contract manufactures, distributes
and markets OTC products and dietary supplements. ProPhase recently
reported fiscal three-month revenues of $3.6 million, up 124% year
over year, as a result of increased customer demand for its OTC
healthcare products.
MZ has developed a distinguished reputation as a
premier resource for institutional investors, brokers, analysts and
private investors. The firm maintains offices worldwide and was
recently ranked No. 7 in the world in business communication by an
IR magazine survey.
Chris Tyson, Executive Vice President at MZ
North America, will advise ProPhase in all facets of corporate and
financial communications, including the coordination of roadshows
and investment conferences across key cities and building brand
awareness with financial and social media outlets.
Ted Haberfield, Chairman & President of MZ
North America, commented: “ProPhase offers disruptive alternatives
to improve treatment results with its performance homeopathic and
allopathic compounds. The Company is well positioned to deliver
long-term value by providing exceptional new products that address
the healthcare and quality of life concerns of the broadest market
segments, particularly in the age of COVID-19. We find the
valuation disconnect at ProPhase to be an exciting opportunity for
investors and look forward to sharing this with our network of
institutional investors and family offices.”
Chris Tyson added: “ProPhase has seen incredible
success in delivering its cutting-edge product line of TK
Supplements®, which promote better health, energy and sexual
vitality. This product line, when combined with the services
offered by the Company’s full-service contract manufacturer and
private label developer subsidiary Pharmaloz Manufacturing, Inc.,
provides an incredible healthcare products platform company with
several exciting avenues for growth. This is in addition to the
Company’s active pursuit of acquisition opportunities to further
expand the breadth of its product offering within the industry,
which we hope to provide an update on in the near-term.”
“2020 has been a pivotal year for the Company,
as we have seen continuous, robust demand growth in the midst of
the COVID-19 pandemic,” said Ted Karkus, Chairman and Chief
Executive Officer of ProPhase. “We are very well positioned to
seize exciting growth opportunities over the next 12 months,
particularly as we enter the 2020 cold season that will be further
exacerbated by the onset of COVID-19. We look forward to working
with Chris and the entire team at MZ Group to communicate our value
proposition to the broader investment community, building long-term
value for our shareholders.”
For more information on ProPhase, please visit
the Company’s investor relations website at www.prophaselabs.com.
To schedule a conference call with management, please email your
request to PRPH@mzgroup.us or call Chris Tyson at 949-491-8235.
About MZ Group
MZ North America is the US division of MZ Group,
a global leader in investor relations and corporate communications.
MZ North America was founded in 1996 and provides full scale
Investor Relations to both private and public companies across all
industries. Supported by our exclusive one‐stop‐shop approach, MZ
works with top management to support the clients' business strategy
in six integrated product and service categories: 1) IR Consulting
& Outreach – full service investor relations and roadshow
services; 2) ESG Consulting – reporting technology platform and
audit and reporting guidance; 3) SPAC Advisory – providing critical
and timely guidance through business combination; 4) Financial
& Social Media – lead generation and social media relations; 5)
Market Intelligence – real time ownership monitoring; 6) Technology
Solutions – webhosting, webcasting, distribution services,
conference calls, CRM, and board portals. MZ North America has a
global footprint with offices located in New York, Chicago, San
Diego, Aliso Viejo, Austin, Minneapolis, Taipei and São Paulo.
About ProPhase Labs
ProPhase Labs (NASDAQ: PRPH) is a manufacturing
and marketing company with deep experience with OTC consumer
healthcare products and dietary supplements. The Company is engaged
in the research, development, manufacture, distribution, marketing
and sale of OTC consumer healthcare products and dietary
supplements in the United States. This includes the development and
marketing of dietary supplements under the TK Supplements®
brand.
In addition, the Company also continues to
actively pursue acquisition opportunities for other companies,
businesses, technologies and products inside and outside the
consumer products industry. For more information visit us at
www.ProPhaseLabs.com.
Forward-Looking Statements
Except for the historical information contained
herein, this document contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the Company’s plans to develop
and implement a comprehensive capital markets strategy with MZ
Group. Management believes that these forward-looking statements
are reasonable as and when made. However, such forward-looking
statements involve known and unknown risks, uncertainties, and
other factors that may cause actual results to differ materially
from those projected in the forward-looking statements. These risks
and uncertainties include, but are not limited to the risk factors
listed from time to time in our Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q and any subsequent SEC filings.
Investor RelationsChris Tyson Executive Vice
President MZ Group – MZ North America (949) 491-8235
PRPH@mzgroup.us www.mzgroup.us
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Apr 2023 to Apr 2024